FIELD: medicine.
SUBSTANCE: present invention refers to new oral compositions containing irreversible gastric H+/K+-ATPase proton pump inhibitor (PPI) as a gastric acid secretion inhibitor and one or more molecules of aliphatic carboxylic acids which activate parietal cells wherein the derivatives induce a delayed or prolonged effect of PPI activity intensification as compared with modified acid molecules.
EFFECT: invention additionally refers to a method for applying such compositions for gastric acid secretion reduction in a mammal.
17 cl, 3 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS TO SUPPRESS GASTRIC JUICE SECRETION | 2005 |
|
RU2385154C2 |
| PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
| COMPOSITION INHIBITING SECRETION OF ACID IN STOMACH | 2003 |
|
RU2340358C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
| TREATMENT OF PHARMACOLOGICALLY INDUCED HYPACIDITY | 2012 |
|
RU2603462C2 |
| NEW MEDICINAL FORMULATIONS OF SUBSTITUTED BENZIMIDAZOLES AND METHOD FOR THEIR USING | 2001 |
|
RU2279276C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
| BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE | 2015 |
|
RU2683317C2 |
| SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
| EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2012 |
|
RU2603471C2 |
